reports
Moody's: Baxter's announced agreement to divest its BioPharma Solution...
Moody's Investors Service (Moody's) commented that the announcement by Baxter International Inc. ("Baxter") that it reached an agreement to divest its BioPharma Solutions ("BPS") business will help in deleveraging and strengthen the company's credit metrics. Baxter (Baa2, stable) will receive $4.25 ...
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
WHR WHIRLPOOL CORPORATION
AMN AMN HEALTHCARE SERVICES INC.
WM WASTE MANAGEMENT INC.
TWI TITAN INTERNATIONAL INC.
PAYX PAYCHEX INC.
NDSN NORDSON CORPORATION
LLY ELI LILLY AND COMPANY
LIVN LIVANOVA PLC
KRNT KORNIT DIGITAL LTD.
KEYS KEYSIGHT TECHNOLOGIES INC
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
J7Z JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
HRL HORMEL FOODS CORPORATION
HAS HASBRO INC.
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
FARO FARO TECHNOLOGIES INC.
EPAM EPAM SYSTEMS INC.
CORT CORCEPT THERAPEUTICS INCORPORATED.
CALX CALIX NETWORKS
BAX BAXTER INTERNATIONAL INC.
AOSL ALPHA & OMEGA SEMICONDUCTOR
ADM ARCHER-DANIELS-MIDLAND COMPANY
SHW SHERWIN-WILLIAMS COMPANY
WMB WILLIAMS COMPANIES INC.
PFE PFIZER INC.
TTEC TTEC HOLDINGS INC.
INVA INNOVIVA INC.
TM. TOYOTA MOTOR CORP. (ADS)
KDP KEURIG DR PEPPER INC.
NIO NIO INC. SPONSORED ADR CLASS A
NLOK NORTONLIFELOCK INC.
TWST TWIST BIOSCIENCE
ITOS ITEOS THERAPEUTICS
BILL BILL.COM HOLDINGS
BEAM BEAM THERAPEUTICS
HRMY HARMONY BIOSCIENCES HOLDINGS
CTKB CYTEK BIOSCIENCES INC
EVA ENVIVA PARTNERS LP
Moody's affirms Baxter International's Baa2 senior unsecured rating; o...
Moody's Investors Service ("Moody's") affirmed Baxter International Inc's ("Baxter") ratings, including its Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook remains stable. The ratings affirmation follows the company's announcement that it plans to spin off its Renal...
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinica...
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022 Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patientsNew ex vivo study demonstrates superior performance of the Theranova dialyzer in effectively balancing higher removal of large middle-molecule toxins and albumin stability during hemodialysis DEERFIELD, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data ...
BAXTER INTERNATIONAL increases its risk exposure and slightly lowers t...
BAXTER INTERNATIONAL (US), a company active in the Medical Equipment industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 2 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date March 18, 2022, the closing price was USD...
Moody's downgrades Baxter International senior unsecured rating to Baa...
Rating Action: Moody's downgrades Baxter International senior unsecured rating to Baa2, stable outlook. Global Credit Research- 16 Dec 2021. New York, December 16, 2021-- Moody's Investors Service downgraded Baxter International Inc.' s senior unsecured rating to Baa2 from Baa1.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.